There are only two methods currently available: condoms and vasectomy. What are the developments that are in the trial period.
For years, many men have dreame of being able to take a pill that would prevent. The women with whom they have sex from getting pregnant. In recent decades, the project of a male contraceptive pill has very well developed. However, the wait seems to be coming to an end, as there are formulas in the trial and testing stage that promise a solution to the issue.
Birth control pill for men is on the way
Male contraceptive options are currently limite to vasectomy and condoms. They are extremely limite compared to female options,” said lead researcher Tamar Jacobsohn of the Contraceptive Development Program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
The specialist added: “The development of an effective and reversible male contraceptive method will improve reproductive choices for men and women, will have a major impact on public health by reducing unintended pregnancies, and will allow men to take an increasingly active role in family planning.” “The positive experiences of men in clinical trials and the high acceptability.
Birth control pill for men is on the way
Currently, there are two male contraceptive pill projects in the pipeline with very good prospects. One of them is the 11-beta-MNTDC, a pill that has already passed phase 1 testing and is on its way to passing further trials. Its creators belong to the University of Washington, work in collaboration with LA BioMed and say that this medication reduces the levels of male hormones necessary for fertilization without having excessive side effects. The study involved 40 men, 10 of whom received a placebo, while the other 30 took a pill containing the compound for 28 days.
Five of them detected a slight reduction in their sexual desire and erection problems, but regardless of these situations, its promoters are convinced that they are on the right track and that the pill could be launched in the near future, although they did not advance dates. The second project also comes from the University of Washington and several other institutions such as the National Institute of Health and the Eunice Kennedy Shriver National Institute. Child Health and Human Development, and is based on the substance dimethandrolone undecanoate (DMAU). Which works in a similar way to 11-beta-MNTDC, suppressing testosterone and two other hormones involved in male fertility.